글로벌 염증성 질환 약물 전달 시장 – 2028년까지의 산업 동향 및 예측

염증성 질환 약물 전달 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 염증성 질환 약물 전달 시장이 2021-2028년 예측 기간 동안 약 7.80%의 CAGR을 보일 것이라고 분석했습니다. 인구 중 염증성 질환의 유병률 증가, 신약 개발을 위한 연구 개발 능력에 대한 지출 증가, 특히 신흥 경제권에서 의료 인프라 개발을 위한 공공 및 민간 지출 증가가 염증성 질환 약물 전달 시장 성장에 기여하는 주요 요인입니다.  

염증은 신체의 면역 체계가 손상된 조직을 회복하기 위해 하는 작용입니다. 그러나 염증성 질환은 면역 체계의 이러한 작용이 손상되는 질환입니다. 따라서 염증성 질환은 암과 류마티스 관절염과 같은 생명을 위협하는 질병으로 이어질 수 있습니다.

크론병과 궤양성 대장염의 유병률 증가는 염증성 질환 약물 전달 시장 가치의 성장을 유도하는 주요 요인 중 하나입니다. 증가하는 연구 개발 활동과 정부의 인식 확산을 위한 이니셔티브 증가는 염증성 질환 약물 전달 시장에 수익성 있고 수익성 있는 성장 기회를 더욱 창출할 것입니다. 노인 인구 증가와 부작용이 낮은 제약 약물에 대한 수요 증가는 염증성 질환 약물 전달 시장 성장의 중요한 요인으로 작용할 것입니다.

그러나 연구 개발 활동에 필요한 높은 자본 투자는 방해가 될 것입니다. 특허 만료 위험은 염증성 질환 약물 전달 시장 성장률에 더욱 도전할 것입니다. 항염증제와 관련된 부작용도 염증성 질환 약물 전달 시장 성장률을 탈선시킬 것입니다.

This inflammatory disease drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on inflammatory disease drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Inflammatory Disease Drug Delivery Market Scope and Market Size

The inflammatory disease drug delivery market is segmented on the basis of type of disease, drug class, distribution channel and route of administration. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• By type of disease, the global inflammatory disease drug delivery market is segmented into respiratory disease, heart disease, multiple sclerosis, psoriasis, inflammatory bowel disease, bone disease and others. Respiratory disease segment is sub-segmented into asthma and chronic obstructive pulmonary disease. Bone disease segment is sub-segmented into rheumatoid arthritis and osteoarthritis.
• On the basis of drug class, the inflammatory disease drug delivery market is segmented into anti- inflammatory biologics, non- steroidal anti- inflammatory drugs, corticosteroids and others.
• On the basis of distribution channel, the inflammatory disease drug delivery market is segmented into hospital pharmacy, drug stores, online pharmacy, retail pharmacy and others.
• On the basis of route of administration, the inflammatory disease drug delivery market is segmented into injectable, inhalation, topical and transdermal, oral and others. Injectable segment is sub-segmented into TNF-inhibitors, IL inhibitors, anti-integrin and others. Oral segment is sub-segmented into ASAs, corticosteroids, JAK inhibitors and others.

Global Inflammatory Disease Drug Delivery Market Country Level Analysis

The inflammatory disease drug delivery market is analysed and market size insights and trends are provided by country, type of disease, drug class, distribution channel and route of administration as referenced above.

The countries covered in the inflammatory disease drug delivery market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the inflammatory disease drug delivery market owing to the rising prevalence of inflammatory diseases and favourable reimbursement scenario in this region. Asia-Pacific on the other hand is projected to undergo the highest growth rate during the forecast period owing to the ever-rising geriatric population and improving healthcare infrastructure.

The country section of the inflammatory disease drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The inflammatory disease drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for inflammatory disease drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the inflammatory disease drug delivery market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Inflammatory Disease Drug Delivery Market Share Analysis

The inflammatory disease drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to inflammatory disease drug delivery market.

염증성 질환 약물 전달 시장 보고서에서 다루는 주요 기업으로는 Mitsubishi Tanabe Pharma Corporation, Gilead Sciences, Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Novartis AG, Astrazeneca, Pfizer Inc., Sanofi, Johnson & Johnson Services, Inc., AbbVie Inc., Allergan, Merck & Co., Inc., Amgen Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Lupin Pharmaceuticals, Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Mylan NV 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-44866